Expertise in
8
conditions

Remi Lhoret-Rabasa

110 Avenue Des Pins Ouest, 
Montreal, QC, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
8
conditions
110 Avenue Des Pins Ouest, 
Montreal, QC, CA 
OverviewLocationsClinical Research

Overview

Remi Lhoret-Rabasa practices in Montreal, Canada. Ms. Lhoret-Rabasa is highly rated in 8 conditions, according to our data. Her top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Cystic Fibrosis, and Obesity.

Her clinical research consists of co-authoring 294 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

110 Avenue Des Pins Ouest, Montreal, QC H2W1R7, Canada
Other Locations
Canada
Ottawa, ON, Canada
Halifax, NS, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

17 Clinical Trials

IRCM Post-COVID-19 (IPCO) Research Clinic: a Multidisciplinary Approach to Evaluate Short and Long-term Complications of COVID-19
IRCM Post-COVID-19 (IPCO) Research Clinic: a Multidisciplinary Approach to Evaluate Short and Long-term Complications of COVID-19
Enrollment Status: Recruiting
Publish Date: April 04, 2024
Intervention Type: Other
Reduction of Basal Insulin to Prevent Hypoglycemia During Two Types of Exercise in Adults and Adolescents With Type 1 Diabetes Using Insulin Pump Therapy
Reduction of Basal Insulin to Prevent Hypoglycemia During Two Types of Exercise in Adults and Adolescents With Type 1 Diabetes Using Insulin Pump Therapy
Enrollment Status: Completed
Publish Date: November 06, 2024
Intervention Type: Other
Study Phase: Not Applicable
Towards Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes With Oral Glucose at a Higher Blood Glucose Threshold
Towards Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes With Oral Glucose at a Higher Blood Glucose Threshold
Enrollment Status: Completed
Publish Date: August 31, 2023
Intervention Type: Device, Other, Drug
Study Phase: Not Applicable
An Open-label, Randomized, Crossover Trial to Assess the Efficacy of Single-hormone Closed-loop System With a Rapid Acting Insulin Analogue Combined With Either Conventional Carbohydrate Counting or a Simplified Qualitative Meal-size Estimation in Regulating Glucose Levels in Adults With Type 1 Diabetes
An Open-label, Randomized, Crossover Trial to Assess the Efficacy of Single-hormone Closed-loop System With a Rapid Acting Insulin Analogue Combined With Either Conventional Carbohydrate Counting or a Simplified Qualitative Meal-size Estimation in Regulating Glucose Levels in Adults With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 28, 2022
Intervention Type: Other, Drug, Device
Study Phase: Not Applicable
Alleviating Carbohydrate-Counting Burden in Type 1 Diabetes Using Artificial Pancreas and Sodium Glucose-Linked Transporter 2 Inhibition: A Randomized Open-Label Crossover Trial.
Alleviating Carbohydrate-Counting Burden in Type 1 Diabetes Using Artificial Pancreas and Sodium Glucose-Linked Transporter 2 Inhibition: A Randomized Open-Label Crossover Trial.
Enrollment Status: Completed
Publish Date: June 24, 2021
Intervention Type: Device, Drug, Behavioral
Study Phase: Not Applicable
Carbohydrates Under Target for Type 1 Diabetes Management
Carbohydrates Under Target for Type 1 Diabetes Management
Enrollment Status: Terminated
Publish Date: February 24, 2021
Intervention Type: Other
Study Phase: Not Applicable
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
Treatment of Mild-to-moderate Hypoglycemia in Adults With Type 1 Diabetes: a Validation Study
Treatment of Mild-to-moderate Hypoglycemia in Adults With Type 1 Diabetes: a Validation Study
Enrollment Status: Completed
Publish Date: September 17, 2020
Intervention Type: Other
Study Phase: Not Applicable
An Open-label, Randomized, Two-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy and Sensor-augmented Pump Therapy in Regulating Glucose Levels for 12 Days in Free-living Outpatient Conditions in Patients With Type 1 Diabetes
An Open-label, Randomized, Two-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy and Sensor-augmented Pump Therapy in Regulating Glucose Levels for 12 Days in Free-living Outpatient Conditions in Patients With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: June 11, 2020
Intervention Type: Other, Drug, Device
Study Phase: Phase 2
Individualized Carbohydrate Intake Strategy to Improve Blood Glucose Control During Team Sports in Children and Adolescents With Type 1 Diabetes: A Carowanis Camp Study
Individualized Carbohydrate Intake Strategy to Improve Blood Glucose Control During Team Sports in Children and Adolescents With Type 1 Diabetes: A Carowanis Camp Study
Enrollment Status: Completed
Publish Date: June 11, 2020
Intervention Type: Other
Study Phase: Not Applicable
Comparison of Two Carbohydrate Intake Strategies to Improve Glucose Control During Exercise in Adolescents and Adults With Type 1 Diabetes
Comparison of Two Carbohydrate Intake Strategies to Improve Glucose Control During Exercise in Adolescents and Adults With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: June 11, 2020
Intervention Type: Other
Study Phase: Not Applicable
An Open-label, Randomized, Two-way, Cross-over Multicenter Study to Assess the Efficacy of Closed-loop Strategy as Compared to Multiple Daily Injections in Regulating Glucose Levels During 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy
An Open-label, Randomized, Two-way, Cross-over Multicenter Study to Assess the Efficacy of Closed-loop Strategy as Compared to Multiple Daily Injections in Regulating Glucose Levels During 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy
Enrollment Status: Completed
Publish Date: June 11, 2019
Intervention Type: Device, Other, Drug
Study Phase: Phase 2
Impact of a Nutritional Intervention on Type1 Diabetes Adult With Metabolic Syndrome
Impact of a Nutritional Intervention on Type1 Diabetes Adult With Metabolic Syndrome
Enrollment Status: Completed
Publish Date: January 31, 2019
Intervention Type: Behavioral
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-controlled Study to Determine Whether Chronic Treatment of Cystic Fibrosis Subjects With Impaired Glucose Tolerance Using Sitagliptin (Januvia) Prevents the Development of Diabetes
A Randomized, Double-blind, Placebo-controlled Study to Determine Whether Chronic Treatment of Cystic Fibrosis Subjects With Impaired Glucose Tolerance Using Sitagliptin (Januvia) Prevents the Development of Diabetes
Enrollment Status: Terminated
Publish Date: June 25, 2018
Intervention Type: Drug
Study Phase: Phase 3
An Open-label, Randomized, Two-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy and Sensor-augmented Pump Therapy in Regulating Glucose Levels for 5 Days in Free-living Outpatient Conditions in Patients With Type 1 Diabetes
An Open-label, Randomized, Two-way, Cross-over Study to Assess the Efficacy of Single-hormone Closed-loop Strategy and Sensor-augmented Pump Therapy in Regulating Glucose Levels for 5 Days in Free-living Outpatient Conditions in Patients With Type 1 Diabetes
Enrollment Status: Withdrawn
Publish Date: January 31, 2018
Intervention Type: Other, Device, Drug
Study Phase: Phase 2
An Open-label, Randomized, Five-way, Cross-over Study to Compare the Efficacy of Single- and Dual-hormone Closed-loop Operations Combined With Either Conventional Carbohydrate Counting or a Simplified Qualitative Meal-size Estimation, and Sensor-augmented Pump Therapy in Regulating Glucose Levels in Children and Adults With Type 1 Diabetes
An Open-label, Randomized, Five-way, Cross-over Study to Compare the Efficacy of Single- and Dual-hormone Closed-loop Operations Combined With Either Conventional Carbohydrate Counting or a Simplified Qualitative Meal-size Estimation, and Sensor-augmented Pump Therapy in Regulating Glucose Levels in Children and Adults With Type 1 Diabetes
Enrollment Status: Withdrawn
Publish Date: October 27, 2017
Intervention Type: Other, Drug, Device
Study Phase: Phase 2
Reduction of Basal Insulin to Prevent Hypoglycemia During Exercise in Adults With Type 1 Diabetes Using Insulin Pump Therapy
Reduction of Basal Insulin to Prevent Hypoglycemia During Exercise in Adults With Type 1 Diabetes Using Insulin Pump Therapy
Enrollment Status: Completed
Publish Date: September 13, 2017
Intervention Type: Other
Study Phase: Not Applicable
View 16 Less Clinical Trials

294 Total Publications

Launching a Living Ethics Initiative to Explore Patients' Psychological Distress in a Highly Specialized Interdisciplinary Care Clinic.
Launching a Living Ethics Initiative to Explore Patients' Psychological Distress in a Highly Specialized Interdisciplinary Care Clinic.
Journal: Qualitative health research
Published: July 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lhoret-Rabasa's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile